Literature DB >> 33586343

Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020 (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012).

Takahiro Nakazawa1, Terumi Kamisawa2, Kazuichi Okazaki3, Shigeyuki Kawa4, Susumu Tazuma5, Takayoshi Nishino6, Dai Inoue7, Itaru Naitoh1, Takayuki Watanabe8, Kenji Notohara9, Kensuke Kubota10, Hirotaka Ohara11, Atsushi Tanaka12, Hajime Takikawa12, Atsushi Masamune13, Tosiaki Unno14.   

Abstract

BACKGROUND: Several years have passed since the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then.
METHODS: The Research Committees for IgG4-related Diseases and for Intractable Diseases of the Liver and Biliary Tract in association with the Ministry of Health, Labor and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4-SC and have drawn up new clinical diagnostic criteria for IgG4-SC 2020.
RESULTS: The diagnosis of IgG4-SC is based on a combination of the following six criteria: (1) narrowing of the intra- or extrahepatic bile duct, (2) thickening of the bile duct wall, (3) serological findings, (4) pathological findings, (5) other organ involvement, and (6) effectiveness of steroid therapy.
CONCLUSION: These new diagnostic criteria for IgG4-SC are useful in practice for general physicians and other non-specialists. This article is protected by copyright. All rights reserved.

Entities:  

Year:  2021        PMID: 33586343     DOI: 10.1002/jhbp.913

Source DB:  PubMed          Journal:  J Hepatobiliary Pancreat Sci        ISSN: 1868-6974            Impact factor:   7.027


  8 in total

Review 1.  Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis.

Authors:  Daniel R Ludwig; Mark A Anderson; Malak Itani; Kedar G Sharbidre; Neeraj Lalwani; Raj M Paspulati
Journal:  Abdom Radiol (NY)       Date:  2022-05-18

Review 2.  Endoscopic retrograde cholangiopancreatography and intraductal ultrasonography in the diagnosis of autoimmune pancreatitis and IgG4-related sclerosing cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa
Journal:  J Med Ultrason (2001)       Date:  2021-07-31       Impact factor: 1.314

Review 3.  IgG4-Related Sclerosing Cholangitis: Rarely Diagnosed, but not a Rare Disease.

Authors:  Sylvia Drazilova; Eduard Veseliny; Patricia Denisa Lenartova; Dagmar Drazilova; Jakub Gazda; Ivica Grgurevic; Martin Janicko; Peter Jarcuska
Journal:  Can J Gastroenterol Hepatol       Date:  2021-12-21

Review 4.  Immunoglobulin G4-related Disease: A New Systemic Disease Emerging in Japan.

Authors:  Terumi Kamisawa
Journal:  JMA J       Date:  2021-12-15

5.  Immunoglobulin G4-Associated Cholangitis: Two Case Reports and Clinical Use of Classic and Emerging International Diagnostic Criteria.

Authors:  Ricardo Jacaranda de Faria; Marcos Vasconcelos Carneiro; Lucio Lucas Pereira; Raissa Dytz; Gabriela Dos Santos
Journal:  J Med Cases       Date:  2022-03-05

6.  IgG4-Related Disease with Hypophysitis and Cholangitis as the Main Manifestations.

Authors:  Yan Huang; Yu Meng Liu; Zhong Hua Lu; Jian He Gan; Wei Feng Zhao; Xiao Ping Huang
Journal:  Dig Dis Sci       Date:  2022-07-05       Impact factor: 3.487

7.  Complemental Diagnosis of IgG4-Related Pancreaticobiliary Diseases by Multiple Hypoechoic Lesions in the Submandibular Glands.

Authors:  Naruki Shimamura; Shinichi Takano; Mitsuharu Fukasawa; Makoto Kadokura; Hiroko Shindo; Ei Takahashi; Sumio Hirose; Yoshimitsu Fukasawa; Satoshi Kawakami; Hiroshi Hayakawa; Natsuhiko Kuratomi; Hiroyuki Hasegawa; Shota Harai; Dai Yoshimura; Naoto Imagawa; Tatsuya Yamaguchi; Taisuke Inoue; Shinya Maekawa; Tadashi Sato; Nobuyuki Enomoto
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

Review 8.  Classification and Diagnostic Criteria for IgG4-Related Sclerosing Cholangitis.

Authors:  Itaru Naitoh; Takahiro Nakazawa
Journal:  Gut Liver       Date:  2022-01-15       Impact factor: 4.519

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.